Comparison of neoadjuvant adriamycin and docetaxel versus adriamycin cyclophosphamide followed by paclitaxel in patients with operable breast cancer

摘要

PurposeNeoadjuvant chemotherapy is the standard treatment for patients with locally advanced breast cancer and is increasingly considered for patients with operable disease. Recently, as many clinical trials have demonstrated favorable outcomes of anthracycline-taxane based regimen, this approach has been widely used in the neoadjuvant setting.